Therapy Areas: Infectious Diseases
NG Biotech unveils COVID-19 antigen self-test Ninonasal for detection of Delta and Epsilon variants across Europe
19 July 2021 -

Infectious disease testing company NG Biotech reported on Friday the launch of the CE marked, highly sensitive COVID-19 antigen self-test Ninonasal for the detection of the Delta and Epsilon variants across Europe within the framework of international sales agreements.

Based in France, the company said the Ninonasal self-test is carried out using nasal samples. The user-friendly Ninonasal enables convenient testing on site and delivers reliable results within a few minutes. It is suitable for testing children under adult supervision.

In contrast to other rapid tests, Ninonasal is clinically confirmed in European hospitals and recognized for simple, frequent tests to detect positive cases and break chains of infection. The special test enables the detection of the alpha, beta, gamma, delta and epsilon variants, added the company.

According to the company, Ninonasal is assembled in France into kits and distributed by Boiron Laboratories for an indigenous French product.



Related Headlines